James S. Miser

6.4k total citations · 1 hit paper
83 papers, 4.4k citations indexed

About

James S. Miser is a scholar working on Pulmonary and Respiratory Medicine, Neurology and Surgery. According to data from OpenAlex, James S. Miser has authored 83 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 22 papers in Neurology and 21 papers in Surgery. Recurrent topics in James S. Miser's work include Sarcoma Diagnosis and Treatment (26 papers), Neuroblastoma Research and Treatments (20 papers) and Pediatric Pain Management Techniques (11 papers). James S. Miser is often cited by papers focused on Sarcoma Diagnosis and Treatment (26 papers), Neuroblastoma Research and Treatments (20 papers) and Pediatric Pain Management Techniques (11 papers). James S. Miser collaborates with scholars based in United States, Taiwan and Canada. James S. Miser's co-authors include Angela W. Miser, Mark Krailo, Mark C. Gebhardt, Holcombe E. Grier, Nancy J. Tarbell, Elizabeth J. Perlman, Paul S. Dickman, Christopher Fryer, Paul A. Meyers and Sarah S. Donaldson and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

James S. Miser

83 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of Bone

2003 948 citations Holcombe E. Grier, Mark Krailo et al. profile →

Peers

Countries citing papers authored by James S. Miser

Since Specialization

Citations

This map shows the geographic impact of James S. Miser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James S. Miser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James S. Miser more than expected).

Fields of papers citing papers by James S. Miser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James S. Miser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James S. Miser. The network helps show where James S. Miser may publish in the future.

Co-authorship network of co-authors of James S. Miser

This figure shows the co-authorship network connecting the top 25 collaborators of James S. Miser. A scholar is included among the top collaborators of James S. Miser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James S. Miser. James S. Miser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An Infant-Type Hemispheric Glioma With SOX5::ALK: A Novel Fusion 2024 ·Journal of the National Comprehensive Cancer Network ·(unknown), (unknown), Chia‐Lang Fang, Kevin Li‐Chun Hsieh, Tsung‐Han Hsieh, Wan‐Ling Ho, Hsi Chang, Min‐Lan Tsai, Yu‐Chien Kao, James S. Miser, Tai‐Tong Wong, (unknown), Yen‐Lin Liu	3
2	Abstract 6723: Application of in vitro drug screening of circulating tumor cells in pediatric glioma therapy 2023 ·Cancer Research ·Yen‐Lin Liu, Yin‐Ju Chen, Shu‐Huey Chen, Yu‐Mei Liao, (unknown), Yi‐Hsuan Chen, Wan‐Ling Ho, (unknown), (unknown), (unknown), (unknown), Pei‐Chin Lin, (unknown), James S. Miser, Tai‐Tong Wong, Yuan‐Hung Wu, (unknown), Thierry Burnouf, Jeng‐Fong Chiou, Long‐Sheng Lu	1
3	Treatment response prediction with circulating tumor cell-derived organoids for soft tissue sarcoma. 2023 ·Journal of Clinical Oncology ·(unknown), Thierry Burnouf, (unknown), Shu‐Huey Chen, Yin‐Ju Chen, Yi‐Hsuan Chen, Wan‐Ling Ho, Yu‐Mei Liao, Pei‐Chin Lin, Yen‐Lin Liu, James S. Miser, (unknown), (unknown), (unknown), Tai‐Tong Wong, (unknown), Yuan‐Hung Wu, Jeng‐Fong Chiou, Long‐Sheng Lu	2
4	Adrenal Crisis Mimicking COVID-19 Encephalopathy in a Teenager with Craniopharyngioma 2022 ·Children ·(unknown), (unknown), Tsai‐Ling Liu, Hsi Chang, Min‐Lan Tsai, Sung‐Hui Tseng, Wan‐Ling Ho, (unknown), Hsiu‐Chen Lin, Jen‐Her Lu, (unknown), Kevin Li‐Chun Hsieh, Tai‐Tong Wong, James S. Miser, Yen‐Lin Liu	1
5	Public Awareness as a Line of Defense Against COVID-19 in Taiwan 2021 ·Asia Pacific Journal of Public Health ·Philip Tseng, Feng‐Jen Tsai, Jason C. Hsu, Yung‐Chun Chang, (unknown), (unknown), Mingchih Chen, (unknown), Ben‐Chang Shia, James S. Miser	2
6	Long-Term Follow-up of High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Children and Young Adults with Metastatic or Relapsed Ewing Sarcoma: A Single-Institution Experience 2020 ·Transplantation and Cellular Therapy ·Anna Pawłowska, (unknown), George T. Calvert, Nicole Karras, Judith K. Sato, (unknown), Jerry C. Cheng, (unknown), (unknown), (unknown), Dongyun Yang, Andrew Dagis, James S. Miser, Joseph Rosenthal	2
7	Seizure characteristics are related to tumor pathology in children with brain tumors 2018 ·Epilepsy Research ·Min‐Lan Tsai, Chi‐Long Chen, Kevin Li‐Chun Hsieh, James S. Miser, Hsi Chang, Yen‐Lin Liu, Tai‐Tong Wong	15
8	Cancer Risk in HBV Patients With Statin and Metformin Use 2015 ·Medicine ·(unknown), (unknown), (unknown), Shing‐Hwa Liu, Ju‐Chi Liu, Lili Wu, (unknown), Hsuan‐Chia Yang, Jaulang Hwang, James S. Miser, Szu‐Yuan Wu	66
9	Risk-directed therapy and research in neuroblastoma 2014 ·Journal of the Formosan Medical Association ·Yen‐Lin Liu, James S. Miser, Wen‐Ming Hsu	3
10	Influenza vaccination reduces hospitalization for acute coronary syndrome in elderly patients with chronic obstructive pulmonary disease: A population-based cohort study 2014 ·Vaccine ·Li‐Chin Sung, (unknown), (unknown), (unknown), (unknown), Tzu‐Hurng Cheng, James S. Miser, Ju‐Chi Liu	49
11	Dose-Intensified Compared With Standard Chemotherapy for Nonmetastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group Study 2009 ·Journal of Clinical Oncology ·Linda Granowetter, Richard B. Womer, Meenakshi Devidas, Mark Krailo, Chenguang Wang, Mark L. Bernstein, Neyssa Marina, Patrick J. Leavey, Mark C. Gebhardt, John H. Healey, Robert C. Shamberger, Allen M. Goorin, James S. Miser, James S. Meyer, Carola A.S. Arndt, Scott L. Sailer, Karen J. Marcus, Elizabeth J. Perlman, Paul S. Dickman, Holcombe E. Grier	235
12	Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: Evaluation of increasing the dose intensity of chemotherapy—a report from the Children's Oncology Group 2007 ·Pediatric Blood & Cancer ·James S. Miser, Robert E. Goldsby, Zhengjia Chen, Mark Krailo, Nancy J. Tarbell, Michael P. Link, Christopher Fryer, Douglas J. Pritchard, Mark C. Gebhardt, Paul S. Dickman, Elizabeth J. Perlman, Paul A. Meyers, Sarah S. Donaldson, Sheila Moore, Aaron R. Rausen, Teresa J. Vietti, Holcombe E. Grier	77
13	Local Control in Pelvic Ewing Sarcoma: Analysis From INT-0091—A Report From the Children's Oncology Group 2006 ·Journal of Clinical Oncology ·Torunn I. Yock, Mark Krailo, Christopher Fryer, Sarah S. Donaldson, James S. Miser, Zhengjia Chen, Mark L. Bernstein, Fran Laurie, Mark C. Gebhardt, Holcombe E. Grier, Nancy J. Tarbell	100
14	Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Chest Wall 2003 ·Annals of Surgery ·Robert C. Shamberger, Michael P. LaQuaglia, Mark C. Gebhardt, James R. Neff, Nancy J. Tarbell, Karen Marcus, Scott L. Sailer, Richard B. Womer, James S. Miser, Paul S. Dickman, Elizabeth J. Perlman, Meenakshi Devidas, Stephen B. Linda, Mark Krailo, Holcombe E. Grier, Linda Granowetter	75
15	Prospective Randomized Trial Between Two Doses of Granulocyte Colony-Stimulating Factor After Ifosfamide, Carboplatin, and Etoposide in Children With Recurrent or Refractory Solid Tumors: A Children's Cancer Group Report 2001 ·The American journal of pediatric hematology/oncology ·Mitchell S. Cairo, Violet Shen, Mark Krailo, Madeline Bauer, James S. Miser, Judith K. Sato, Julie Blatt, Bruce R. Blazar, Sharon Frierdich, Wen Liu‐Mares, Gregory H. Reaman	45
16	Intensive combined modality therapy of small round cell and undifferentiated sarcomas in children and young adults: local control and patterns of failure 1989 ·Radiotherapy and Oncology ·Judith L. Bader, Marc E. Horowitz, (unknown), E. Blake Watkins, Timothy J. Triche, Maria Tsokos, Timothy J. Kinsella, James S. Miser, Seth M. Steinberg, Eli Glatstein	19
17	The role of resection in the treatment of pulmonary metastases from Ewing’s sarcoma 1987 ·Journal of Thoracic and Cardiovascular Surgery ·Louis A. Lanza, James S. Miser, Harvey I. Pass, Jack A. Roth	30
18	Transient neonatal leukemoid reactions in mosaic trisomy 21 1984 ·The Journal of Pediatrics ·Nita L. Seibel, (unknown), James S. Miser	56
19	Evaluation of growth hormone release and human growth hormone treatment in children with cranial irradiation-associated short stature 1984 ·The Journal of Pediatrics ·Carolyn A. Romshe, William B. Zipf, Angela W. Miser, James S. Miser, Juan F. Sotos, William A. Newton	80
20	Continuous intravenous infusion of morphine sulfate for control of severe pain in children with terminal malignancy 1980 ·The Journal of Pediatrics ·Angela W. Miser, James S. Miser, Barbara S. Clark	82

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact